Benchmarking emerging chromatographic platforms for mRNA-LNP characterization and scalable process enablement
Lipid nanoparticles (LNPs) are now the leading delivery platform for nucleic acid therapeutics, supporting applications from prophylactic mRNA vaccines to in vivo gene editing, in vivo CAR-T, protein replacement, and personalized cancer immunotherapy. As formulations incorporate novel ionizable lipids, targeting ligand...
Sergeja Lebar, Tristan Kovačič, Ana Ferjančič Budihna et al.
· Cell and Gene Therapy Insigh... · 0 citations